StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$233.08−10.17 (-4.18%)

Close on Nov 18, 2026Market cap $13.80BP/E –Yield –

Glaukos revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Glaukos's revenue for the twelve months ending Sep 30, 2026 was $690.33M, up 46.9% year over year. For fiscal 2025 it was $507.44M, up 32.3% from the year before. Over ten years it grew 21.6% a year on average. The highest annual figure on record is $507.44M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$507.44M+32.3%
FY2024Dec 31, 2024$383.48M+21.9%
FY2023Dec 31, 2023$314.71M+11.3%
FY2022Dec 31, 2022$282.86M-3.8%
FY2021Dec 31, 2021$294.01M+30.7%
FY2020Dec 31, 2020$224.96M-5.1%
FY2019Dec 31, 2019$236.98M+30.7%
FY2018Dec 31, 2018$181.28M+13.8%
FY2017Dec 31, 2017$159.25M+39.2%
FY2016Dec 31, 2016$114.40M+59.5%
FY2015Dec 31, 2015$71.70M+57.3%
FY2014Dec 31, 2014$45.59M+117.6%
FY2013Dec 31, 2013$20.95M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$211.03M+58.0%
Q2 FY2026Jun 30, 2026$185.61M+49.5%
Q1 FY2026Mar 31, 2026$150.57M+41.2%
Q4 FY2025Dec 31, 2025$143.12M+35.7%
Q3 FY2025Sep 30, 2025$133.54M+38.1%
Q2 FY2025Jun 30, 2025$124.12M+29.7%
Q1 FY2025Mar 31, 2025$106.66M+24.6%
Q4 FY2024Dec 31, 2024$105.50M+28.1%
Q3 FY2024Sep 30, 2024$96.67M+23.9%
Q2 FY2024Jun 30, 2024$95.69M+19.0%
Q1 FY2024Mar 31, 2024$85.62M+15.9%
Q4 FY2023Dec 31, 2023$82.37M+15.6%
Q3 FY2023Sep 30, 2023$78.05M+9.5%
Q2 FY2023Jun 30, 2023$80.40M+10.6%
Q1 FY2023Mar 31, 2023$73.90M+9.2%
Q4 FY2022Dec 31, 2022$71.23M-2.7%
Q3 FY2022Sep 30, 2022$71.27M-4.6%
Q2 FY2022Jun 30, 2022$72.69M-6.9%
Q1 FY2022Mar 31, 2022$67.68M-0.4%
Q4 FY2021Dec 31, 2021$73.24M+0.0%
Q3 FY2021Sep 30, 2021$74.71M+15.2%
Q2 FY2021Jun 30, 2021$78.09M+147.5%
Q1 FY2021Mar 31, 2021$67.97M+22.8%
Q4 FY2020Dec 31, 2020$73.23M+11.2%
Q3 FY2020Sep 30, 2020$64.83M+10.8%
Q2 FY2020Jun 30, 2020$31.56M-46.1%
Q1 FY2020Mar 31, 2020$55.34M+2.4%
Q4 FY2019Dec 31, 2019$65.85M+21.8%
Q3 FY2019Sep 30, 2019$58.51M+33.3%
Q2 FY2019Jun 30, 2019$58.60M+35.8%
Q1 FY2019Mar 31, 2019$54.03M+34.6%
Q4 FY2018Dec 31, 2018$54.08M+29.8%
Q3 FY2018Sep 30, 2018$43.91M+8.7%
Q2 FY2018Jun 30, 2018$43.16M+4.5%
Q1 FY2018Mar 31, 2018$40.13M+11.8%
Q4 FY2017Dec 31, 2017$41.65M+25.6%
Q3 FY2017Sep 30, 2017$40.41M–
Q2 FY2017Jun 30, 2017$41.29M–
Q1 FY2017Mar 31, 2017$35.91M–
Q4 FY2016Dec 31, 2016$33.17M–

More Glaukos figures

See a number that looks wrong?